
Combination of Radioligand Therapy and Immunotherapy: How to Make It Work in Clinic?
Introduction Introduction of immunotherapy into the clinic in 2011 in the form of anti-CTLA4 immune checkpoint inhibitors has drastically changed the landscape of oncology, producing spectacular results in some patients with metastatic melanoma.1 Those …